Statistics from Altmetric.com
A recent editorial discusses how the Fluid Expansion as Supportive Therapy (FEAST) trial,1 the only phase III randomised controlled trial assessing fluid bolus therapy (FBT) in severely ill African children, had little impact on guidelines despite the increased mortality risk in children receiving FBT. The editorial mentions the 2013 WHO guideline which partially considers the FEAST trial results, and the 2014 American College of Critical Care Medicine guideline which does not.
We reviewed paediatric sepsis guidelines from the USA, the Surviving Sepsis Campaign and …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.